Orthopoxviral disease

Clinical trials for Orthopoxviral disease explained in plain language.

Never miss a new study

Get alerted when new Orthopoxviral disease trials appear

Sign up with your email to follow new studies for Orthopoxviral disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Antiviral tecovirimat put to the test for smallpox threat

Prevention Completed

Researchers tested two doses of tecovirimat, an antiviral drug, in healthy volunteers to see how safe and well-tolerated it is. Participants took a daily oral dose for 14 days, and researchers monitored side effects and measured drug levels in the blood. The goal was to find the …

Matched conditions: ORTHOPOXVIRAL DISEASE

Phase 2 • Sponsor: SIGA Technologies • Aim: Prevention

Last updated Sep 13, 2026 00:00 UTC

Orthopoxviral disease

Get alerted when new Orthopoxviral disease trials appear

Antiviral tecovirimat put to the test for smallpox threat